|
Davidson et al. (1991)
|
Cohort
|
study #2 (subset of study #1) 104 cases for whom all medical records were available (U.S-.Alaska natives)
|
Exposure to DTwP† vaccination determined from public health immunization records and computerized Indian Health Service medical records
|
Occurrence of all illness during the 30-day period before and after DTwP administration. Categories include: any illness; any infectious disease; otitis media; other respiratory infections; temperature > 38°C; and hospitalization
|
For all illness, 53% of all children had illnesses during 30 days before DTwP immunization and 43% had illnesses during 30 days after DTwP immunization (p = .004); Other illness categories were non-significant; any infectious disease (p = .084); otitis media (p = .501); other respiratory infections (p = 0.285); temp>38°C (p = .724); hospitalization (p = .424)
|
potential for over matching
|
Weak evidence relevant to causality; favors no effect of DTwP vaccine
|
|
BCG = Bacille Calmette-Guerin vaccine
MMR = measles-mumps-rubella vaccine
DTaP = diphtheria-tetanus-acellular pertussis
DTwP = diphtheria-tetanus-whole-cell pertussis
Hep B = hepatitis B vaccine
Hib = Haemophilus influenzae b vaccine
OPV = oral polio virus
HMO: health maintenance organization
NS = not significant
CI = confidence interval
OR = odds ratio
RR = relative risk
*These studies do not specify whether acellular or whole-cell pertussis vaccine was administered. It is assumed that whole-cell pertussis vaccine was administered to children in these studies.
† Diphtheria-tetanus-whole cell pertussis vaccine
|